1
|
Catanesi M, Panella G, Benedetti E, Fioravanti G, Perrozzi F, Ottaviano L, Leandro LD, Ardini M, Giansanti F, d'Angelo M, Castelli V, Angelucci F, Ippoliti R, Cimini A. YAP/TAZ mechano-transduction as the underlying mechanism of neuronal differentiation induced by reduced graphene oxide. Nanomedicine (Lond) 2018; 13:3091-3106. [PMID: 30451074 DOI: 10.2217/nnm-2018-0269] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
AIM The aim of this work is the dissection of the molecular pathways underlying the differentiation effect of reduced graphene oxide (GO) materials in the absence of differentiation agents. MATERIALS & METHODS Reduced GO is obtained either by drop casting method and heat-treated or biological reduction by the interaction between GO and wtPrxI. Cells were grown on both materials and the differentiation process studied by immunological and morphological detection. RESULTS & CONCLUSION The results obtained indicate that both reduction methods of GO can determine the modulation of pathway involved in mechano-transduction and differentiation, by affecting YAP/TAZ localization outside the nuclei and increasing neuronal differentiation markers. This suggests that the mechano-transduction pathways are responsible for the differentiation process.
Collapse
Affiliation(s)
- M Catanesi
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - G Panella
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - E Benedetti
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - G Fioravanti
- Department of Physical & Chemical Sciences, University of L'Aquila, L'Aquila Italy
| | - F Perrozzi
- Department of Physical & Chemical Sciences, University of L'Aquila, L'Aquila Italy
| | - L Ottaviano
- Department of Physical & Chemical Sciences, University of L'Aquila, L'Aquila Italy
| | - L Di Leandro
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - M Ardini
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - F Giansanti
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - M d'Angelo
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - V Castelli
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - F Angelucci
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - R Ippoliti
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy
| | - A Cimini
- Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila Italy.,Department of Biology, Sbarro Institute for Cancer Research & Molecular Medicine, Temple University, PA, USA
| |
Collapse
|
2
|
Pascarella A, Terracciano C, Farina O, Lombardi L, Esposito T, Napolitano F, Franzese G, Panella G, Tuccillo F, la Marca G, Bernardini S, Boffo S, Giordano A, Di Iorio G, Melone MAB, Sampaolo S. Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy. J Cell Physiol 2018; 233:5829-5837. [PMID: 29215735 DOI: 10.1002/jcp.26365] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2017] [Accepted: 11/30/2017] [Indexed: 12/18/2022]
Abstract
Autosomal recessive Pompe disease is a lysosomal disorder caused by mutations of the acid-α-glucosidase (GAA) gene. Deficiency of GAA enzyme leads to glycogen accumulation and autophagy impairment in cardiac and skeletal muscles, but also in lymphocytes. Since an effective therapy is available, a rapid, sensitive, and specific test is crucial to early identify affected subjects. Number of lymphocytes containing PAS-positive vacuoles was evaluated on blood films from 72 consecutive adult patients with hyperckemia and/or muscle weakness, 13 genetically confirmed late-onset-Pompe-disease (LOPD) and 13 of their offspring. GAA activity, measured on dried blood spot (DBS) in all patients inversely correlated with number of PAS-positive lymphocytes. More than 4 PAS-positive lymphocytes were found in 11 out of the 72 patients (6 new diagnosis of LOPD, 3 different glycogen storage myopathies, 1 glucose-6-phosphate dehydrogenase deficiency, 1 caveolinopathy), in all 13 LOPD patients and in the 13 LOPD offspring. These latter resulted to have all a single GAA mutation but low GAA levels. Immunostaining with the autophagy markers LC3 and p62 confirmed the autophagic nature of lymphocytes vacuoles. ROC curve assessment of PAS-positive lymphocytes disclosed 100% of sensitivity and 94% of specificity in recognizing both compound heterozygous and heterozygous GAA carriers. The other myopathies with more than 4 PAS-positive lymphocytes appeared to be all related to impaired autophagy, which seems to be responsible of PAS-positive vacuolated lymphocytes formation. Quantification of PAS-positive lymphocytes in blood films is useful to identify autophagic vacuolar myopathies and should be routinely used as first level test for Pompe disease.
Collapse
Affiliation(s)
- Angelo Pascarella
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy.,Neurorehabilitation Unit and Research Lab. for Disorder of Consciousness, Maugeri ICS, Telese Terme, Italy
| | - Chiara Terracciano
- Division of Clinical Biochemistry, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy
| | - Olimpia Farina
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Luca Lombardi
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Teresa Esposito
- Molecular Genetics and Genomics Laboratory, Institute of Genetics and Biophysics, "Adriano Buzzati Traverso", Italian National Research Council (CNR), Naples, Italy.,IRCCS INM Neuromed, Pozzilli, Italy
| | - Filomena Napolitano
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Giuseppina Franzese
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Giovanni Panella
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Francesco Tuccillo
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Giancarlo la Marca
- Department of Experimental and Clinical Biomedical Sciences, University of Florence; Head, Newborn Screening, Clinical Chemistry and Pharmacology Lab, Meyer Offspring's Hospital, Florence, Italy
| | - Sergio Bernardini
- Division of Clinical Biochemistry, Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy
| | - Silvia Boffo
- Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania
| | - Antonio Giordano
- Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.,Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy
| | - Giuseppe Di Iorio
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| | - Mariarosa A B Melone
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy.,Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania
| | - Simone Sampaolo
- 2nd Division of Neurology, Department of Medicine, Surgery, Neurology, Metabolic and Aging Science, Reference Center for Neurological and Neuromuscular Rare Disease & Interuniversity Center for Research in Neurosciences, University of Campania "Luigi Vanvitelli", Naples, Italy
| |
Collapse
|
3
|
Massaccesi C, Colella S, Fioretti F, D'Emilio V, Panella G, Primomo G, Barbisan F, Pela R, Poletti V. An unusual thoracic localizations of Erdheim- Chester disease: A case report. Respir Med Case Rep 2017; 20:116-119. [PMID: 28149747 PMCID: PMC5271674 DOI: 10.1016/j.rmcr.2017.01.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2016] [Revised: 01/10/2017] [Accepted: 01/11/2017] [Indexed: 02/08/2023] Open
Abstract
Erdheim- Chester disease is a rare non- Langerhans cell histiocytosis that usually involves the bones, heart, central nervous system, retroperitoneum, eyes, kidneys, skin and adrenals. Lungs are affected in up to one-half cases; at CT scan various patterns are described: interstitial disease, consolidations, micronodules and microcysts, with or without pleural involvement. We presented a case of a 59 year-old man with unusual intrathoracic manifestation of Erdheim- Chester disease. Singularities of our report are the lonely thoracic involvement at the onset of the disease and a histiocytic lesion in the posterior mediastinum.
Collapse
Affiliation(s)
- C Massaccesi
- Pulmonary Unit, "C. e G. Mazzoni" Hospital, Ascoli Piceno, Italy
| | - S Colella
- Pulmonary Unit, "C. e G. Mazzoni" Hospital, Ascoli Piceno, Italy
| | - F Fioretti
- Pulmonary Unit, "C. e G. Mazzoni" Hospital, Ascoli Piceno, Italy
| | - V D'Emilio
- Pulmonary Unit, "C. e G. Mazzoni" Hospital, Ascoli Piceno, Italy
| | - G Panella
- Pulmonary Unit, "C. e G. Mazzoni" Hospital, Ascoli Piceno, Italy
| | - G Primomo
- Pulmonary Unit, "C. e G. Mazzoni" Hospital, Ascoli Piceno, Italy
| | - F Barbisan
- Department of Pathology, "Ospedali Riuniti", Ancona, Italy
| | - R Pela
- Pulmonary Unit, "C. e G. Mazzoni" Hospital, Ascoli Piceno, Italy
| | - V Poletti
- Department of Diseases of the Thorax, GB Morgagni Hospital, Forlì, Italy; Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark
| |
Collapse
|
4
|
Calamari L, Soriani N, Panella G, Petrera F, Minuti A, Trevisi E. Rumination time around calving: an early signal to detect cows at greater risk of disease. J Dairy Sci 2014; 97:3635-47. [PMID: 24731630 DOI: 10.3168/jds.2013-7709] [Citation(s) in RCA: 85] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2013] [Accepted: 02/26/2014] [Indexed: 11/19/2022]
Abstract
The main objective of this experiment was to evaluate the use of rumination time (RT) during the peripartum period as a tool for early disease detection. The study was carried out in an experimental freestall barn and involved 23 Italian Friesian cows (9 primiparous and 14 multiparous). The RT was continuously recorded by using an automatic system (Hr-Tag, SCR Engineers Ltd., Netanya, Israel), and data were summarized in 2-h intervals. Blood samples were collected from 30 d before calving to 42 d in milk (DIM) to assess biochemical indicators related to energy, protein, and mineral metabolism, as well as markers of inflammation and some enzyme activities. The liver functionality index, which includes some negative acute-phase proteins and related parameters (albumin, cholesterol, and bilirubin), was used to evaluate the severity of inflammatory conditions occurring around calving. The cows were retrospectively categorized according to RT observed between 3 and 6 DIM into those with the lowest (L) and highest (H) RT. The average RT before calving (-20 to -2d) was 479 min/d (range 264 to 599), reached a minimum value at calving (30% of RT before calving), and was nearly stable after 15 DIM (on average 452 min/d). Milk yield in early lactation (on average 26.8 kg/d) was positively correlated with RT (r = 0.33). After calving, compared with H cows, the L cows had higher values of haptoglobin (0.61 and 0.34 g/L at 10 DIM in L and H, respectively) for a longer time, had a greater increase in total bilirubin (9.5 and 5.7 μmol/L at 5 DIM in L and H), had greater reductions of albumin (31.2 and 33.5 g/L at 10 DIM in L and H) and paraoxonase (54 and 76 U/ml at 10 DIM in L and H), and had a slower increase of total cholesterol (2.7 and 3.2 mmol/L at 20 DIM in L and H). Furthermore, a lower average value of liver functionality index was observed in L (-6.97) compared with H (-1.91) cows. These results suggest that severe inflammation around parturition is associated with a slower increase of RT after calving. Furthermore, more than 90% of the cows in the L group had clinical diseases in early lactation compared with 42% of the H cows. Overall, our results demonstrate the utility of monitoring RT around calving, and in particular during the first week of lactation, as a way to identify in a timely fashion those cows at a greater risk of developing a disease in early lactation.
Collapse
Affiliation(s)
- L Calamari
- Istituto di Zootecnica, Università Cattolica del Sacro Cuore, Via Emilia Parmense, 84, 29122 Piacenza, Italy.
| | - N Soriani
- Istituto di Zootecnica, Università Cattolica del Sacro Cuore, Via Emilia Parmense, 84, 29122 Piacenza, Italy
| | - G Panella
- Azienda Sperimentale "Vittorio Tadini," 29027 Gariga di Podenzano, Piacenza, Italy
| | - F Petrera
- Consiglio per la Ricerca e la sperimentazione in Agricoltura (Centro di Ricerca per le Produzioni Foraggere e Lattiero-Casearie), sede di Cremona, via Porcellasco 7, 26100 Cremona, Italy
| | - A Minuti
- Istituto di Zootecnica, Università Cattolica del Sacro Cuore, Via Emilia Parmense, 84, 29122 Piacenza, Italy
| | - E Trevisi
- Istituto di Zootecnica, Università Cattolica del Sacro Cuore, Via Emilia Parmense, 84, 29122 Piacenza, Italy
| |
Collapse
|